Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of Paclitaxel/Carboplatin and Lonafarnib
to those of Paclitaxel/Carboplatin in primary treatment of patients with epithelial ovarian
cancer.